Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture

American Journal of Epidemiology

Volumn 171, Issue 12, 2010, Pages 1317-1322

  Kim, Helen ^a   McCulloch, Charles E ^a   Johnston, S Claiborne ^a   Lawton, Michael T ^a   Sidney, Stephen ^b   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Arteriovenous malformations; Intracranial hemorrhages; Risk factors; Survival analysis

Indexed keywords

BRAIN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HEALTH RISK; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; QUANTITATIVE ANALYSIS; RISK FACTOR; SURVIVAL;

ADULT; ARTERY RUPTURE; ARTICLE; BIRTH; BOOTSTRAPPING; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CLINICAL EVALUATION; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGE FACTORS; ARTERIOVENOUS FISTULA; CALIFORNIA; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; INTRACRANIAL HEMORRHAGES; KAPLAN-MEIERS ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

CALIFORNIA; UNITED STATES;

EID: 77953223925     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq082     Document Type: Article

References (28)

1. Stapf C, Mohr JP, Choi JH, et al. Invasive treatment of un-ruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol. 2006;19(1):63-68.
2. Stapf C, Mohr JP. Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke. 2007; 38(12):3308-3309.
3. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350- 1355.
4. Kim H, Sidney S, McCulloch CE, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38(9): 2430-2437.
5. Yamada S, Takagi Y, Nozaki K, et al. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg. 2007;107(5):965-972.
6. Hernesniemi JA, Dashti R, Juvela S, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823-829.
7. Pollock BE, Flickinger JC, Lunsford LD, et al. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1):1-6.
8. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IVand Varteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003; 98(1):3-7.
9. Achrol AS, Pawlikowska L, McCulloch CE, et al. Tumor necrosis factor-alpha-238G
10. Pawlikowska L, Poon KY, Achrol AS, et al. Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery. 2006;58(5): 838-843.
11. Halim AX, Johnston SC, Singh V, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004;35(7):1697-1702.
12. Willemse RB, Mager JJ, Westermann CJ, et al. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000;92(5):779-784.
13. Fullerton HJ, Achrol AS, Johnston SC, et al. Long-term hemorrhage risk in children versus adults with brain arterio-venous malformations. Stroke. 2005;36(10):2099-2104.
14. Du R, Hashimoto T, Tihan T, et al. Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg. 2007; 106(3):470-477.
15. Fuwa I, Wada H, Matsumoto T. Recurrence of AVM after disappearing on postoperative angiography\report of two cases [in Japanese]. No Shinkei Geka. 1988;16(7):887-891.
16. Gabriel EM, Sampson JH, Wilkins RH. Recurrence of a cerebral arteriovenous malformation after surgical excision. Case report. J Neurosurg. 1996;84(5):879-882.
17. Hashimoto N, Nozaki K. Do cerebral arteriovenous malformations recur after angiographically confirmed total extirpation? Crit Rev Neurosurg. 1999;9(3):141-146.
18. Higuchi M, Bitoh S, Hasegawa H, et al. Marked growth of arteriovenous malformation 19 years after resection: a case report [in Japanese]. No Shinkei Geka. 1991;19(1):75-78.
19. Kader A, Goodrich JT, Sonstein WJ, et al. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg. 1996;85(1):14-18.
20. Kondziolka D, Humphreys RP, Hoffman HJ, et al. Arteriove-nous malformations of the brain in children: a forty year experience. Can J Neurol Sci. 1992;19(1):40-45.
21. Pellettieri L, Svendsen P, Wikholm G, et al. Hidden compartments in AVMs\a new concept. Acta Radiol. 1997;38(1): 2-7.
22. Yasargil MG. Microneurosurgery. Stuttgart, Germany: Georg Thieme Verlag; 1988.
23. Klimo P Jr, Rao G, Brockmeyer D. Pediatric arteriovenous malformations: a 15-year experience with an emphasis on residual and recurrent lesions. Childs Nerv Syst. 2007;23(1): 31-37.
24. Sonstein WJ, Kader A, Michelsen WJ, et al. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg. 1996;85(5):838-845.
25. Gordon NP. How Does the Adult Kaiser Permanente Membership in Northern California Compare with the Larger Community? Oakland, CA: Kaiser Permanente Division of Research; 2006. (http://www.dor.kaiser.org/external/DORExternal/mhs/ comparison2003.aspx). (Accessed May 1, 2009).
26. Breslow NE, Lubin JH, Marek P, et al. Multiplicative models and cohort analysis. J Am Stat Assoc. 1983;78(381): 1-12.
27. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145(1):72-80.
28. Thiébaut AC, Bénichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004;23(24):3803-3820.